| Literature DB >> 28753517 |
Abdulrahman I Almansour1, Natarajan Arumugam2, Raju Suresh Kumar1, S M Mahalingam3, Samaresh Sau3, Giulia Bianchini4, J Carlos Menéndez5, Mohammad Altaf6, Hazem A Ghabbour7.
Abstract
A small library of benzimidazole-fused pyrrolo[3,4-b]quinoline has been synthesized from readily available benzimidazole 2-carbaldehyde and various substituted arylamines in good to excellent yields utilizing an intramolecular Povarov reaction catalyzed by boron trifluoride diethyl etharate as the key final step. The compounds thus synthesized can be considered as decarbonyl analogues of the anticancer alkaloid luotonin A and were evaluated in a DNA relaxation assay for their ability to inhibit human topoisomerase I. Interestingly, two of the compounds showed a remarkable activity that is comparable to that of the standard drug camptothecin. The compounds were also evaluated for their cytotoxic effect in four highly aggressive human cancer cell lines, namely KB, MDA-MB231 (breast), LNCap (prostate), and HT1080 (fibrosarcoma). Some of the compounds obtained showed promising cytotoxicities for these four cell lines.Entities:
Keywords: Antiproliferative activity; Benzimidazole fused pyrrolo[3,4-b]quinoline; Decarbonyl analogues of luotonin; Molecular docking; Povarov reaction
Mesh:
Substances:
Year: 2017 PMID: 28753517 DOI: 10.1016/j.ejmech.2017.07.027
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514